Obesity Drugs Excluded From Medicare Part D, Even For Non-Cosmetic Use
The Medicare Part D prescription drug program will not cover weight-loss drugs for any purpose, whether cosmetic or not, the Centers for Medicare & Medicaid Services said in an update to its Q&A for the program
You may also be interested in...
Drugs to treat "morbid obesity" may be covered by Medicare Part D plans despite the exclusion of "weight loss agents" from the program, CMS indicated in the final rules implementing the Medicare Rx benefit
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials